SETTING: To reduce the risk of tuberculosis (TB) among individuals with human
immunodeficiency virus (HIV) infection, the World Health Organization recommends at least …

SETTING: Despite worldwide scale-up of human immunodeficiency virus (HIV) care
services, relatively few countries have implemented isoniazid preventive therapy (IPT) …

Setting Four primary health care clinics providing tuberculosis (TB) and Human
Immunodeficiency Virus care services in Bulawayo, Zimbabwe. Objectives To assess …

Introduction Despite high rates of successful treatment TB incidence in South Africa remains
high, suggesting ongoing transmission and a large reservoir of latently infected persons …

Background Isoniazid preventive therapy (IPT) is given to HIV patients to reduce the risk of
active tuberculosis (TB). However, treatment completion remains suboptimal among those …

SETTING: Isoniazid preventive therapy (IPT) has not been widely implemented due to
questions about acceptance, adherence and side effects. OBJECTIVE: To examine factors …

Background Proper adherence to isoniazid preventive therapy (IPT) may depend upon the
results of tuberculosis (TB) screening test and patients' understanding of their risk of …

SETTING: The World Health Organization recommends the use of isoniazid preventive
therapy (IPT) for human immunodeficiency virus (HIV) infected patients with a positive …

Background: Despite proven benefits of isoniazid preventive therapy (IPT) for people living
with HIV (PLHIV), its implementation remains limited in low-resource settings. There are also …

Objective Data on feasibility and completion rates of isoniazid preventive therapy (IPT) in
HIV‐infected patient in Asia are limited. Within a hospital‐based HIV programme in Phnom …